These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

224 related articles for article (PubMed ID: 31119060)

  • 1. Application of next-generation sequencing technology to precision medicine in cancer: joint consensus of the Tumor Biomarker Committee of the Chinese Society of Clinical Oncology.
    Zhang X; Liang Z; Wang S; Lu S; Song Y; Cheng Y; Ying J; Liu W; Hou Y; Li Y; Liu Y; Hou J; Liu X; Shao J; Tai Y; Wang Z; Fu L; Li H; Zhou X; Bai H; Wang M; Lu Y; Yang J; Zhong W; Zhou Q; Yang X; Wang J; Huang C; Liu X; Zhou X; Zhang S; Tian H; Chen Y; Ren R; Liao N; Wu C; Zhu Z; Pan H; Gu Y; Wang L; Liu Y; Zhang S; Liu T; Chen G; Shao Z; Xu B; Zhang Q; Xu R; Shen L; Wu Y; Tumor Biomarker Committee OBOCSOCOC
    Cancer Biol Med; 2019 Feb; 16(1):189-204. PubMed ID: 31119060
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Chinese expert consensus on the analytical validation of tumor comprehensive genomic profiling next generation sequencing testing (2024 edition)].
    ;
    Zhonghua Zhong Liu Za Zhi; 2024 Apr; 46(4):274-284. PubMed ID: 38644265
    [TBL] [Abstract][Full Text] [Related]  

  • 3. How to read a next-generation sequencing report-what oncologists need to know.
    Schmid S; Jochum W; Padberg B; Demmer I; Mertz KD; Joerger M; Britschgi C; Matter MS; Rothschild SI; Omlin A
    ESMO Open; 2022 Oct; 7(5):100570. PubMed ID: 36183443
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Good Laboratory Standards for Clinical Next-Generation Sequencing Cancer Panel Tests.
    Kim J; Park WY; Kim NKD; Jang SJ; Chun SM; Sung CO; Choi J; Ko YH; Choi YL; Shim HS; Won JK;
    J Pathol Transl Med; 2017 May; 51(3):191-204. PubMed ID: 28535585
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Molecular tests and target therapies in oncology: recommendations from the Italian workshop.
    Pinto C; Biffoni M; Popoli P; Marchetti A; Marchetti P; Martini N; Normanno N
    Future Oncol; 2021 Sep; 17(26):3529-3539. PubMed ID: 34254524
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Precision cancer medicine: What has translated into clinical use in Belgium?
    Delnord M; Van Valckenborgh E; Hebrant A; Antoniou A; Van Hoof W; Waeytens A; Van den Bulcke M
    Semin Cancer Biol; 2022 Sep; 84():255-262. PubMed ID: 34129914
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Next Generation Sequencing (NGS): A Revolutionary Technology in Pharmacogenomics and Personalized Medicine in Cancer.
    Morganti S; Tarantino P; Ferraro E; D'Amico P; Duso BA; Curigliano G
    Adv Exp Med Biol; 2019; 1168():9-30. PubMed ID: 31713162
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Portuguese Consensus Recommendations for Next-Generation Sequencing of Lung Cancer, Rare Tumors, and Cancers of Unknown Primary Origin in Clinical Practice.
    R Teixeira M; Oliveira J; Borralho P; O Fernandes MG; Almodovar T; Fernandes I; Macedo D; Ferreira A; Barroso A; Teixeira E; Machado JC
    Acta Med Port; 2022 Sep; 35(9):677-690. PubMed ID: 35816050
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [A review of consensus statements, practice resources, standards and guidelines for clinical applications of next-generation sequencing technologies in the United States].
    Zhao C; Xie X; Ji W; Qi M; Zhou Q; Li M; Li P; Jiang Y; Zhang H
    Zhonghua Yi Xue Yi Chuan Xue Za Zhi; 2021 Jun; 38(6):513-520. PubMed ID: 34096016
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Molecular Tumor Board as a Clinical Tool for Converting Molecular Data Into Real-World Patient Care.
    Vingiani A; Agnelli L; Duca M; Lorenzini D; Damian S; Proto C; Niger M; Nichetti F; Tamborini E; Perrone F; Piccolo A; Manoukian S; Azzollini J; Brambilla M; Colombo E; Lopez S; Vernieri C; Marra F; Conca E; Busico A; Capone I; Bozzi F; Angelini M; Devecchi A; Salvatori R; De Micheli V; Baggi A; Pasini S; Jommi C; Ladisa V; Apolone G; De Braud F; Pruneri G
    JCO Precis Oncol; 2023 Jul; 7():e2300067. PubMed ID: 37487147
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Artificial intelligence (AI) and big data in cancer and precision oncology.
    Dlamini Z; Francies FZ; Hull R; Marima R
    Comput Struct Biotechnol J; 2020; 18():2300-2311. PubMed ID: 32994889
    [TBL] [Abstract][Full Text] [Related]  

  • 12. FDA-led consortium studies advance quality control of targeted next generation sequencing assays for precision oncology.
    Li D; Kusko R; Ning B; Tong W; Johann DJ; Xu J
    Precis Cancer Med; 2021 Dec; 4():. PubMed ID: 35282311
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Clinical practice recommendations for the use of next-generation sequencing in patients with solid cancer: a joint report from KSMO and KSP.
    Kim M; Shim HS; Kim S; Lee IH; Kim J; Yoon S; Kim HD; Park I; Jeong JH; Yoo C; Cheon J; Kim IH; Lee J; Hong SH; Park S; Jung HA; Kim JW; Kim HJ; Cha Y; Lim SM; Kim HS; Lee CK; Kim JH; Chun SH; Yun J; Park SY; Lee HS; Cho YM; Nam SJ; Na K; Yoon SO; Lee A; Jang KT; Yun H; Lee S; Kim JH; Kim WS
    J Pathol Transl Med; 2024 Jul; 58(4):147-164. PubMed ID: 39026440
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Consensus Statements on Precision Oncology in the China Greater Bay Area.
    Lam TC; Cho WC; Au JS; Ma ES; Lam ST; Loong HH; Wong JWH; Wong SNM; Lee VH; Leung RC; Lau JK; Kam MT; Mok FS; Lim FM; Nyaw JS; Tin WW; Cheung KM; Chan OS; Kwong PW; Cheung FY; Poon DMC; Chik JY; Lam MH; Chan LW; Wong SC; Cao YB; Hui CV; Chen JZ; Chang JH; Kong SF; El Helali A;
    JCO Precis Oncol; 2023 Jun; 7():e2200649. PubMed ID: 37315266
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Design of targeted, capture-based, next generation sequencing tests for precision cancer therapy.
    Hagemann IS; Cottrell CE; Lockwood CM
    Cancer Genet; 2013 Dec; 206(12):420-31. PubMed ID: 24388712
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Navigating the rapids: the development of regulated next-generation sequencing-based clinical trial assays and companion diagnostics.
    Pant S; Weiner R; Marton MJ
    Front Oncol; 2014; 4():78. PubMed ID: 24860780
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Next-Generation Sequencing and Result Interpretation in Clinical Oncology: Challenges of Personalized Cancer Therapy.
    Khotskaya YB; Mills GB; Mills Shaw KR
    Annu Rev Med; 2017 Jan; 68():113-125. PubMed ID: 27813876
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Complexity of genome sequencing and reporting: Next generation sequencing (NGS) technologies and implementation of precision medicine in real life.
    Morganti S; Tarantino P; Ferraro E; D'Amico P; Viale G; Trapani D; Duso BA; Curigliano G
    Crit Rev Oncol Hematol; 2019 Jan; 133():171-182. PubMed ID: 30661654
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Next-generation sequencing in precision oncology: challenges and opportunities.
    Kruglyak KM; Lin E; Ong FS
    Expert Rev Mol Diagn; 2014 Jul; 14(6):635-7. PubMed ID: 24791810
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Bioinformatic data processing pipelines in support of next-generation sequencing-based HIV drug resistance testing: the Winnipeg Consensus.
    Ji H; Enns E; Brumme CJ; Parkin N; Howison M; Lee ER; Capina R; Marinier E; Avila-Rios S; Sandstrom P; Van Domselaar G; Harrigan R; Paredes R; Kantor R; Noguera-Julian M
    J Int AIDS Soc; 2018 Oct; 21(10):e25193. PubMed ID: 30350345
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.